Enzymes having alpha amylase activity and methods of use thereof

Details for Australian Patent Application No. 2012238328 (hide)

Owner Verenium Corporation

Inventors Callen, Walter; Frey, Gerhard; Richardson, Toby

Agent Freehills

Pub. Number AU-A-2012238328

Parent 2009222426

Filing date 11 October 2012

Wipo publication date 1 November 2012

International Classifications

C12N 9/28 Enzymes, e.g. ligases (6.)

C07K 16/40 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 1/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

C12P 19/14 Preparation of compounds containing saccharide radicals

C12P 21/08 Preparation of peptides or proteins - Monoclonal antibodies

C12Q 1/40 Measuring or testing processes involving enzymes or micro-organisms - involving amylase

Event Publications

25 October 2012 Complete Application Filed

1 November 2012 Application Open to Public Inspection

  Published as AU-A-2012238328

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012238329-Apparatus and Method for Recovering Fluids From a Well and/or Injecting Fluids into a Well

2012238327-Stable atorvastatin formulations